Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.24%
1,103.05
+2.67
+0.24%
—1,100.381,096.191,112.971,094.08——
SIXC
Communications
SIXC
Communications
SIXC
+0.19%
622.42
+1.21
+0.19%
—621.21621.21624.47618.56——
SIXE
Energy
SIXE
Energy
SIXE
-2.87%
1,157.44
-34.22
-2.87%
—1,191.661,158.281,160.761,124.17——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.82%
1,750.30
+31.25
+1.82%
—1,719.051,729.911,766.941,729.91——
SIXM
Financials
SIXM
Financials
SIXM
+0.75%
646.61
+4.84
+0.75%
—641.77643.39653.21643.39——
SIXR
Staples
SIXR
Staples
SIXR
+1.26%
833.78
+10.40
+1.26%
—823.38822.99834.38820.61——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.54%
218.49
+3.31
+1.54%
—215.18215.18218.76215.18——
SIXT
Technology
SIXT
Technology
SIXT
+1.50%
3,109.02
+45.83
+1.50%
—3,063.193,096.933,118.043,093.29——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.42%
935.18
-3.92
-0.42%
—939.10937.35937.41924.95——
SIXV
Health care
SIXV
Health care
SIXV
+1.45%
1,503.60
+21.56
+1.45%
—1,482.041,485.591,506.801,485.59——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+2.36%
2,435.30
+56.09
+2.36%
—2,379.212,409.512,463.802,409.51——
Macrogen Inc
₩17,350.00
+0.75%
(+130.00) 1D
Apr 17, 3:30:22 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 038290...
Open
₩17,400
High
₩17,680
Low
₩17,210
Mkt. cap
188.10B
Avg. vol.
30.16K
Volume
38.31K
Dividend
2.88%
Quarterly dividend
₩125
Ex dividend date
Dec 27, 2024
P/E ratio
92.66
52-wk high
₩20,900
52-wk low
₩14,720
EPS
₩187
Shares outstanding
10.84M
No. of employees
475
News stories
From sources across the web
Profile
Macrogen, Inc. is a South Korean public biotechnology company. The company's headquarters are located in Seoul. The company was founded in 1997 by Jeong-sun Seo, a professor at Seoul National University. It was venture capital-backed until its initial public offering and subsequent listing on the KOSDAQ market in 2000, making it the first Korean biotechnology firm to raise funds through an IPO. The company announced plans in 2010 to map the "Korean genome" based on the notion that United States-backed genome mapping efforts up to that time were representative of the "Caucasian genome" rather than the "Human genome" as claimed. By 2015, the company was described by one news outlet as "a global leader in personalized genomic medicine". Wikipedia
About Macrogen Inc
CEOChanghoon Kim | Seo Jeong-seon
Employees475
FoundedJun 5, 1997
Headquarters-
SectorHealth care
Websitemacrogen.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
40.96B
48.99B
49.06B
56.26B
Cost of goods sold
27.02B
32.32B
30.68B
35.05B
Cost of revenue
27.02B
32.32B
30.68B
35.05B
Research and development expenses
-
-
-
4.12B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.59B
17.35B
17.10B
6.79B
Operating expense
16.98B
18.19B
17.27B
17.57B
Total operating expenses
44.01B
50.51B
47.95B
52.62B
Operating income
-3.05B
-1.53B
1.11B
3.64B
Other non operating income
-64.46M
-696.27M
985.86M
2.18B
EBT including unusual items
-3.22B
-2.32B
2.04B
3.49B
EBT excluding unusual items
-3.22B
-2.32B
2.04B
2.30B
Income tax expense
-44.67M
-55.36M
-46.70M
339.81M
Effective tax rate
1.39%
2.39%
-2.28%
9.75%
Other operating expenses
-
-
-
1.37B
Net income
-2.22B
-1.59B
2.46B
3.38B
Net profit margin
-5.42%
-3.24%
5.01%
6.00%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
748.82M
Interest expense
-
-
-
-2.52B
Net interest expenses
-
-
-
-1.77B
Depreciation and amortization charges
-
-
-
3.66B
EBITDA
-346.40M
1.17B
3.81B
7.98B
Gain or loss from assets sale
-
-
-
88.53M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer